Esclerosis Múltiple y Neuromielitis Óptica

Advances in clinical trial of a worldwide pioneering technique to treat Multiple Sclerosis

GAEM Foundation finished the first phase of its clinical trial of a pioneering technique to treat Multiple Sclerosis and Optic Neuromyelitis The clinical trial  “Dendritic Cell Specific Antigen Therapy”, a worldwide pioneering technique that aims to modulate the defenses of the Multiple Sclerosis and Optic Neuromyelitis patients, has culminated its first phase, focused on verifying…